Evidence map›Paper›PMID 22230731›Full record

Trial reportHealth and quality of life outcomes2012

The validity and precision of the Leicester Cough Questionnaire in COPD patients with chronic cough.

Farida F Berkhof, Lisenka N Boom, Nynke E ten Hertog, Steven M Uil, Huib A M Kerstjens, Jan W K van den Berg

Registry-linked trialAbstract readComparative StudyRandomized Controlled TrialValidation Study
In one paragraph

Trial report in Health and quality of life outcomes, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01071161 (Phase III), which is not on this map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01071161 phase3completednot on this map

Phase III (c) The Effect of Azithromycin in Patients With COPD and Chronic Productive Cough

TypeinterventionalSponsorIsalaRan2009 to 2012Enrolled84ConditionsCough, Chronic Obstructive Pulmonary Disease, Chronic BronchitisArmsazithromycin, placebo
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults.European respiratory review : an official journal of the European Respiratory Society · 2019
    Pooled it
  2. Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Cross-cultural adaptation and validation of Leicester Cough Questionnaire in sarcoidosis: the persian version.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Farida F BerkhofIsala klinieken, department of pulmonary diseases, Zwolle, The Netherlands. f.f.berkhof@isala.nl
Lisenka N Boom
Nynke E ten Hertog
Steven M Uil
Huib A M Kerstjens
Jan W K van den Berg

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA validated instrument to assess the effects of chronic cough on health status in patients with chronic obstructive pulmonary disease (COPD) is currently not available. The Leicester Cough Questionnaire (LCQ) is a cough-specific health status questionnaire which is originally validated for a population of general patients presenting with chronic cough. We examined the psychometric performance of the LCQ in patients with COPD and chronic productive cough.

methodsConcurrent validity, internal consistency, reproducibility and responsiveness were determined. The St. George's Respiratory Questionnaire (SGRQ) and the Short Form-36 (SF-36) were used as external criteria. Questionnaires were completed at the start of the study. After 2 and 12 weeks the LCQ was repeated, together with a global rating of change.

resultsIn total 54 patients were included. Concurrent validity analysis showed significant correlations between corresponding domains of the LCQ and the SGRQ (r(s) -0.31 to -0.60). Corresponding domains of the LCQ and the SF-36 showed weaker correlations (r(s) 0.04 to 0.41). Internal consistency was adequate for two of the three domains (Cronbach's α 0.74 - 0.86). Test-retest reliability in stable patients was high (intraclass correlation coefficients 0.79 - 0.93). The mean difference after two weeks was 0.73 (± 1.75). Responsiveness analysis indicated that the LCQ was able to detect changes after 12 weeks.

conclusionThe LCQ is a valid, reliable, responsive instrument to measure health status in COPD patients with chronic productive cough.

trial registrationClinicalTrials.gov: NCT01071161.

Indexed as

Age FactorsAzithromycinChronic DiseaseCoughDose-Response Relationship, DrugDrug Administration ScheduleFemaleFollow-Up StudiesHumansMaleMiddle AgedProspective StudiesPulmonary Disease, Chronic ObstructiveReproducibility of ResultsRisk FactorsSex FactorsAzithromycin

Identifiers

PMID22230731
PMCPMC3311606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.